Back to news

Autonomix Medical Rises as Patent Focus Returns and Thin Share Count Amplifies Trading

Investivoq PriceTracker

Autonomix Medical (AMIX) is up 16.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be renewed investor attention around Autonomix’s patent pipeline and broader regulatory story, rather than a brand-new operating update. This could be because a patent-related item circulated before the open, while the company’s relatively small public share count may have made the stock especially sensitive to speculative buying.

Details:

  • The company’s most recent SEC filing was a November 3 current report tied to its annual meeting, board matters, and an increase in shares authorized under its 2023 stock plan, not a major clinical or commercial announcement.
  • Autonomix said on September 30 that FDA pre-submission feedback supported a 510(k) pathway for its standalone sensing platform, giving investors a regulatory milestone to watch.
  • On October 2, the company announced stronger patent protection for catheter-based platform technology tied to transvascular access, treatment delivery, and procedural validation, reinforcing the intellectual-property theme around the stock.
  • A late-August registration filing showed about 1.83 million shares outstanding as of August 31, 2026, which helps explain why modest buying interest can translate into outsized percentage moves.

    • Sources:

    SEC, Autonomix Medical Investor Relations, USPTO, Finviz

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    EARLY ACCESS
    Receive AMIX Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $AMIX Hedge Fund Activity

    We have seen 4 institutional investors add shares of $AMIX stock to their portfolio, and 11 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • GEODE CAPITAL MANAGEMENT, LLC added 48,639 shares (+inf%) to their portfolio in Q3 2026, for an estimated $186,287
    • UBS GROUP AG removed 33,497 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $208,686
    • LPL FINANCIAL LLC removed 31,435 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $195,840
    • BANK OF MONTREAL /CAN/ removed 25,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $155,750
    • VIRTU FINANCIAL LLC removed 12,884 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $80,267
    • MARINER, LLC removed 2,772 shares (-5.2%) from their portfolio in Q2 2026, for an estimated $17,269
    • IKARIAN CAPITAL, LLC removed 890 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $5,544

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.